ArticleBMC medical genomics2022

Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study.

Mark P van Opijnen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.